RxDoctor Payments Data

Patricia Rivera

Medical · McAllen, TXNPI 1134450232

Payments from drug & device makers

$9,569in general payments, 2019–2025

Across 286 payments — averaging $33.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Medtronic$2K
  • Biotronik Inc.$1K
  • E.r. Squibb & Sons, L.L.C.$818
  • Johnson & Johnson$728
  • Lilly USA, LLC$565
  • plus $3K from 21 others

What the payments were for

  • Travel & lodging$1,52016%
  • Food & beverage$7,91583%
  • Education$1341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,569 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan84$129,037
XareltoRivaroxaban30$47,107
EliquisApixaban26$43,877
FarxigaDapagliflozin Propanediol14$13,134
Ranolazine ErRanolazine31$3,733
Metoprolol Tartrate166$862
Nitroglycerin35$788
Diltiazem Hcl21$624
Furosemide115$609
Losartan Potassium62$535
ClopidogrelClopidogrel Bisulfate46$515
Atorvastatin Calcium67$503
Hydralazine Hcl28$305
Lisinopril43$303
Ibuprofen15$279

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$484$129,03784 claims
Johnson & JohnsonXarelto$728$47,10730 claims
PfizerEliquis$110$43,87726 claims
AstraZenecaFarxiga$248$13,13414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,490 medical providers in Texas.

Other medical in McAllen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →